(-)-epigallocatechin 3-gallate increases expression ISO RGD:1343142 6480464 epigallocatechin gallate results in increased expression of MYOF protein CTD PMID:31195006 (S)-nicotine increases splicing ISO RGD:1343142 6480464 Nicotine results in increased splicing of MYOF mRNA alternative form CTD PMID:23825647 1,1-dichloroethene increases expression ISO RGD:1557416 6480464 vinylidene chloride results in increased expression of MYOF mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression ISO RGD:1557416 6480464 1, 2-Dimethylhydrazine results in increased expression of MYOF mRNA CTD PMID:22206623 17beta-estradiol affects expression ISO RGD:1343142 6480464 Estradiol affects the expression of MYOF mRNA CTD PMID:22574217 17beta-estradiol increases expression ISO RGD:1343142 6480464 Estradiol results in increased expression of MYOF mRNA CTD PMID:19484750 17beta-estradiol increases expression ISO RGD:1557416 6480464 Estradiol results in increased expression of MYOF mRNA CTD PMID:19484750 17beta-estradiol multiple interactions ISO RGD:1343142 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of MYOF mRNA, [Estradiol co-treated with Progesterone] results in increased expression of MYOF mRNA CTD PMID:20660070 , PMID:20823114 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1343142 6480464 Dihydrotestosterone results in increased expression of MYOF mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine decreases methylation ISO RGD:1557416 6480464 Tetrachlorodibenzodioxin results in decreased methylation of MYOF gene CTD PMID:21212295 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MYOF mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1557416 6480464 Tetrachlorodibenzodioxin results in decreased expression of MYOF mRNA CTD PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MYOF mRNA CTD PMID:32109520 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1557416 6480464 Tetrachlorodibenzodioxin affects the expression of MYOF mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1343142 6480464 Tetrachlorodibenzodioxin results in increased expression of MYOF mRNA CTD PMID:19692669 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1343142 6480464 [Tetrachlorodibenzodioxin co-treated with AHR mRNA] affects the expression of MYOF mRNA CTD PMID:20619336 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:1343142 6480464 3 more ... CTD PMID:19692669 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1343142 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MYOF mRNA more ... CTD PMID:28628672 3-methylcholanthrene multiple interactions ISO RGD:1343142 6480464 Methylcholanthrene promotes the reaction [AHR protein binds to MYOF promoter] CTD PMID:20348232 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1343142 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MYOF mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:1557416 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of MYOF mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:1557416 6480464 Fenretinide results in decreased expression of MYOF mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide increases expression ISO RGD:1557416 6480464 Fenretinide results in increased expression of MYOF mRNA CTD PMID:28973697 5-fluorouracil decreases expression ISO RGD:1343142 6480464 Fluorouracil results in decreased expression of MYOF protein CTD PMID:15352031 5-fluorouracil affects response to substance ISO RGD:1343142 6480464 MYOF protein affects the susceptibility to Fluorouracil CTD PMID:15352031 8-Br-cAMP increases expression ISO RGD:1343142 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MYOF mRNA CTD PMID:22079614 acetamide increases expression EXP 6480464 acetamide results in increased expression of MYOF mRNA CTD PMID:31881176 afimoxifene multiple interactions ISO RGD:1343142 6480464 afimoxifene inhibits the reaction [Estrogens results in increased expression of MYOF mRNA] CTD PMID:21233418 aflatoxin B1 affects expression ISO RGD:1343142 6480464 Aflatoxin B1 affects the expression of MYOF protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:1343142 6480464 Aflatoxin B1 results in decreased methylation of MYOF intron CTD PMID:30157460 aflatoxin B1 increases expression ISO RGD:1343142 6480464 Aflatoxin B1 results in increased expression of MYOF mRNA CTD PMID:27153756 aflatoxin B1 increases methylation ISO RGD:1343142 6480464 Aflatoxin B1 results in increased methylation of MYOF exon, Aflatoxin B1 results in increased methylation of MYOF gene CTD PMID:27153756 , PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1343142 6480464 Tretinoin results in increased expression of MYOF mRNA CTD PMID:21934132 , PMID:33167477 all-trans-retinoic acid multiple interactions ISO RGD:1557416 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of MYOF mRNA, [bisphenol F co-treated with Tretinoin] results in decreased expression of MYOF mRNA CTD PMID:30951980 arsenite(3-) multiple interactions ISO RGD:1343142 6480464 arsenite inhibits the reaction [G3BP1 protein binds to MYOF mRNA] CTD PMID:32406909 arsenous acid decreases expression ISO RGD:1343142 6480464 Arsenic Trioxide results in decreased expression of MYOF mRNA CTD PMID:19128835 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of MYOF mRNA CTD PMID:36841081 belinostat increases expression ISO RGD:1343142 6480464 belinostat results in increased expression of MYOF mRNA CTD PMID:26272509 benzo[a]pyrene decreases expression ISO RGD:1557416 6480464 Benzo(a)pyrene results in decreased expression of MYOF mRNA CTD PMID:19770486 benzo[a]pyrene increases methylation ISO RGD:1557416 6480464 Benzo(a)pyrene results in increased methylation of MYOF exon, Benzo(a)pyrene results in increased methylation of MYOF intron CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1343142 6480464 Benzo(a)pyrene results in increased expression of MYOF mRNA CTD PMID:20106945 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1343142 6480464 7 more ... CTD PMID:19150397 beta-naphthoflavone increases expression ISO RGD:1343142 6480464 beta-Naphthoflavone results in increased expression of MYOF mRNA CTD PMID:19737606 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1343142 6480464 Diethylhexyl Phthalate results in increased expression of MYOF mRNA CTD PMID:31163220 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MYOF mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1343142 6480464 bisphenol A results in increased expression of MYOF protein CTD PMID:34186270 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MYOF mRNA CTD PMID:30816183 bisphenol A multiple interactions ISO RGD:1557416 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of MYOF mRNA CTD PMID:30951980 bisphenol A increases expression ISO RGD:1557416 6480464 bisphenol A results in increased expression of MYOF mRNA CTD PMID:30951980 , PMID:33221593 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of MYOF gene CTD PMID:28505145 bisphenol A multiple interactions ISO RGD:1343142 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MYOF mRNA CTD PMID:28628672 Bisphenol B increases expression ISO RGD:1343142 6480464 bisphenol B results in increased expression of MYOF protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:1343142 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MYOF mRNA CTD PMID:28628672 bisphenol F increases expression ISO RGD:1343142 6480464 bisphenol F results in increased expression of MYOF protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1557416 6480464 bisphenol F results in increased expression of MYOF mRNA CTD PMID:30951980 bisphenol F multiple interactions ISO RGD:1557416 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of MYOF mRNA CTD PMID:30951980 bucladesine multiple interactions ISO RGD:1343142 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of MYOF mRNA CTD PMID:20823114 butan-1-ol multiple interactions ISO RGD:1343142 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MYOF mRNA CTD PMID:29432896 butanal decreases expression ISO RGD:1343142 6480464 butyraldehyde results in decreased expression of MYOF mRNA CTD PMID:26079696 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of MYOF mRNA CTD PMID:19167457 caffeine increases expression ISO RGD:1343142 6480464 Caffeine results in increased expression of MYOF protein CTD PMID:31195006 cantharidin increases expression ISO RGD:1557416 6480464 Cantharidin results in increased expression of MYOF mRNA CTD PMID:36907384 carbamazepine affects expression ISO RGD:1343142 6480464 Carbamazepine affects the expression of MYOF mRNA CTD PMID:25979313 chlordecone increases expression ISO RGD:1557416 6480464 Chlordecone results in increased expression of MYOF mRNA CTD PMID:33711761 chloropicrin increases expression ISO RGD:1343142 6480464 chloropicrin results in increased expression of MYOF mRNA CTD PMID:26352163 choline multiple interactions ISO RGD:1557416 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MYOF mRNA CTD PMID:20938992 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of MYOF mRNA CTD PMID:22023808 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of MYOF mRNA CTD PMID:24386269 cobalt dichloride decreases expression ISO RGD:1343142 6480464 cobaltous chloride results in decreased expression of MYOF mRNA CTD PMID:19320972 copper(II) sulfate increases expression ISO RGD:1343142 6480464 Copper Sulfate results in increased expression of MYOF mRNA CTD PMID:19549813 coumestrol increases expression ISO RGD:1343142 6480464 Coumestrol results in increased expression of MYOF mRNA CTD PMID:19167446 cyclosporin A increases expression ISO RGD:1343142 6480464 Cyclosporine results in increased expression of MYOF mRNA CTD PMID:20106945 , PMID:27989131 cytarabine decreases expression ISO RGD:1343142 6480464 Cytarabine results in decreased expression of MYOF mRNA CTD PMID:21198554 daidzein multiple interactions ISO RGD:1343142 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of MYOF mRNA CTD PMID:27424125 daidzein 7-O-beta-D-glucoside multiple interactions ISO RGD:1343142 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of MYOF mRNA CTD PMID:27424125 dexamethasone multiple interactions ISO RGD:1343142 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MYOF mRNA more ... CTD PMID:28628672 diarsenic trioxide decreases expression ISO RGD:1343142 6480464 Arsenic Trioxide results in decreased expression of MYOF mRNA CTD PMID:19128835 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of MYOF mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO RGD:1557416 6480464 Dibutyl Phthalate results in increased expression of MYOF mRNA CTD PMID:21266533 dorsomorphin multiple interactions ISO RGD:1343142 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1343142 6480464 Doxorubicin results in decreased expression of MYOF mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of MYOF mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1343142 6480464 entinostat results in increased expression of MYOF mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1343142 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYOF mRNA CTD PMID:27188386 fenamidone increases expression ISO RGD:1557416 6480464 fenamidone results in increased expression of MYOF mRNA CTD PMID:27029645 folic acid multiple interactions ISO RGD:1557416 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MYOF mRNA CTD PMID:20938992 formaldehyde decreases expression ISO RGD:1343142 6480464 Formaldehyde results in decreased expression of MYOF mRNA CTD PMID:20655997 furan increases expression EXP 6480464 furan results in increased expression of MYOF mRNA CTD PMID:27387713 genistein increases methylation EXP 6480464 Genistein results in increased methylation of MYOF gene CTD PMID:28505145 genistein multiple interactions ISO RGD:1343142 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of MYOF mRNA CTD PMID:27424125 genistein 7-O-beta-D-glucoside multiple interactions ISO RGD:1343142 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of MYOF mRNA CTD PMID:27424125 glycitein multiple interactions ISO RGD:1343142 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of MYOF mRNA CTD PMID:27424125 glycitin multiple interactions ISO RGD:1343142 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of MYOF mRNA CTD PMID:27424125 hydrogen peroxide affects expression ISO RGD:1343142 6480464 Hydrogen Peroxide affects the expression of MYOF mRNA CTD PMID:20044591 indometacin multiple interactions ISO RGD:1343142 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MYOF mRNA more ... CTD PMID:28628672 ivermectin decreases expression ISO RGD:1343142 6480464 Ivermectin results in decreased expression of MYOF protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:1557416 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MYOF mRNA CTD PMID:20938992 lipopolysaccharide decreases methylation ISO RGD:1557416 6480464 Lipopolysaccharides results in decreased methylation of MYOF gene CTD PMID:21212295 lipopolysaccharide multiple interactions ISO RGD:1343142 6480464 [S-(1 more ... CTD PMID:35811015 medroxyprogesterone acetate multiple interactions ISO RGD:1343142 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of MYOF mRNA CTD PMID:20823114 mercury dibromide increases expression ISO RGD:1343142 6480464 mercuric bromide results in increased expression of MYOF mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1343142 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYOF mRNA CTD PMID:27188386 methylmercury chloride increases expression ISO RGD:1343142 6480464 methylmercuric chloride results in increased expression of MYOF mRNA CTD PMID:28001369 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of MYOF mRNA, [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of MYOF promoter CTD PMID:25374375 nickel atom decreases expression ISO RGD:1343142 6480464 Nickel results in decreased expression of MYOF mRNA CTD PMID:23195993 nickel sulfate increases expression ISO RGD:1343142 6480464 nickel sulfate results in increased expression of MYOF mRNA CTD PMID:16780908 nicotine increases splicing ISO RGD:1343142 6480464 Nicotine results in increased splicing of MYOF mRNA alternative form CTD PMID:23825647 ochratoxin A decreases expression ISO RGD:1343142 6480464 ochratoxin A results in decreased expression of MYOF protein CTD PMID:26861962 ozone multiple interactions ISO RGD:1557416 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MYOF mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MYOF mRNA CTD PMID:34911549 p-chloromercuribenzoic acid increases expression ISO RGD:1343142 6480464 p-Chloromercuribenzoic Acid results in increased expression of MYOF mRNA CTD PMID:26272509 panobinostat increases expression ISO RGD:1343142 6480464 panobinostat results in increased expression of MYOF mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1343142 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYOF mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:1557416 6480464 Acetaminophen affects the expression of MYOF mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of MYOF mRNA CTD PMID:33387578 phenobarbital multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of MYOF mRNA, [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of MYOF promoter CTD PMID:25374375 phenylmercury acetate increases expression ISO RGD:1343142 6480464 Phenylmercuric Acetate results in increased expression of MYOF mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1343142 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYOF mRNA CTD PMID:27188386 progesterone decreases expression ISO RGD:1343142 6480464 Progesterone results in decreased expression of MYOF mRNA CTD PMID:18037150 progesterone multiple interactions ISO RGD:1343142 6480464 [Estradiol co-treated with Progesterone] results in increased expression of MYOF mRNA CTD PMID:20660070 quercetin increases expression ISO RGD:1343142 6480464 Quercetin results in increased expression of MYOF mRNA CTD PMID:21632981 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1343142 6480464 [S-(1 more ... CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:1343142 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of MYOF mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1343142 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1343142 6480464 Silicon Dioxide analog results in increased expression of MYOF mRNA CTD PMID:25895662 silver atom increases expression ISO RGD:1557416 6480464 Silver results in increased expression of MYOF mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:1557416 6480464 Silver results in increased expression of MYOF mRNA CTD PMID:27131904 sirolimus multiple interactions ISO RGD:1343142 6480464 Sirolimus inhibits the reaction [TP73 protein results in increased expression of MYOF mRNA] CTD PMID:21245298 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of MYOF protein CTD PMID:29459688 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of MYOF mRNA CTD PMID:22110744 sunitinib decreases expression ISO RGD:1343142 6480464 Sunitinib results in decreased expression of MYOF mRNA CTD PMID:31533062 tetrachloromethane increases expression ISO RGD:1557416 6480464 Carbon Tetrachloride results in increased expression of MYOF mRNA CTD PMID:29987408 thapsigargin increases expression ISO RGD:1557416 6480464 Thapsigargin results in increased expression of MYOF protein CTD PMID:24648495 trichostatin A increases expression ISO RGD:1343142 6480464 trichostatin A results in increased expression of MYOF mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1343142 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYOF mRNA CTD PMID:27188386 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1343142 6480464 tris(2-butoxyethyl) phosphate affects the expression of MYOF mRNA CTD PMID:29024780 urethane decreases expression ISO RGD:1343142 6480464 Urethane results in decreased expression of MYOF mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:1343142 6480464 Valproic Acid results in decreased expression of MYOF mRNA, Valproic Acid results in decreased expression of MYOF protein CTD PMID:29154799 , PMID:29501571 valproic acid affects methylation ISO RGD:1343142 6480464 Valproic Acid affects the methylation of MYOF gene CTD PMID:29501571 valproic acid multiple interactions ISO RGD:1343142 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYOF mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1343142 6480464 Valproic Acid results in increased expression of MYOF mRNA CTD PMID:23179753 more ... vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of MYOF mRNA CTD PMID:19015723 vitamin E decreases expression ISO RGD:1343142 6480464 Vitamin E results in decreased expression of MYOF mRNA CTD PMID:19244175 vorinostat increases expression ISO RGD:1343142 6480464 vorinostat results in increased expression of MYOF mRNA CTD PMID:26272509
